Evidence map›Paper›PMID 41282895›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Differential Clearance of [

James Russell, Milan Grkovski, Joseph A O'Donoghue, Alexandre Franca-Velo, Simone Krebs, Lisa Bodei, Heiko Schöder, John L Humm

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

James RussellDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY.
Milan GrkovskiDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0001-7228-9497
Joseph A O'DonoghueDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0002-2761-0015
Alexandre Franca-VeloDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0001-9786-4136
Simone KrebsDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0002-9909-4531
Lisa BodeiDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0001-6930-7383
Heiko SchöderDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0002-5170-4185
John L HummDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0003-4245-5591

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Interrogating the in vivo pharmacokinetics of armored CARs with radiohapten captureR37CA262557 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Simone Krebs · 2021 to 2026
$3.4M
IL13Ra2-targeted radioimmunotherapy for glioblastomaR21CA294042 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KREBS, SIMONE · 2025 to 2025
$432k
NCI NIH HHS P30 CA008748NCI NIH HHS R21 CA294042NCI NIH HHS R37 CA262557
6 · The paper itself

Abstract

Background: DNA repair inhibitors may safely enhance targeted radiotherapy if they can be administered when radioisotope has cleared from critical normal tissues. We investigated whether the kinetics of [ Materials and Methods: Pluvicto effective t Results: Pluvicto clearance is almost 3× faster in normal organs-at-risk compared to lesions. Using pre-clinical estimates of DDRi sensitization, a meaningful increase in lesion effective treatment dose could be achieved with minor additional risk to normal organs.

Indexed as

[177Lu]Lu-PSMA-617DNA damage repair inhibitormetastatic castrate resistant prostate cancerPluvictoradiosensitizer

Identifiers

PMID41282895
PMCPMC12632677

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.